Personal care composition containing ozone-stressed yeast lysates

ABSTRACT

The present invention relates to an ozone-stressed yeast lysate, and a personal care composition including an ozone-stressed yeast lysate and at least one preservative selected from the group consisting of alcohols, glycols, parabens, hydantoins, quaternary nitrogen-containing compounds, isothiazolinones, aldehyde-releasing agents, and halogenated compounds. The present invention also relates to a method for preparing and using the ozone-stressed yeast lysate and the personal care composition.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional PatentApplication Ser. No. 60/618,698, filed on Oct. 13, 2004, entitled“Personal Care Composition Containing Ozone-Stressed Yeast Lysates”, thedisclosure of which is incorporated herein by reference in its entirety.

FIELD OF THE INVENTION

This invention relates generally to personal care compositions, and morespecifically to such compositions containing ozone-stressed yeastlysates.

BACKGROUND OF THE INVENTION

Ozone is increasingly becoming recognized as a detrimental agent forskin cells. Ozone can affect lipids, proteins, nucleic acids and sugarsbut is especially severe to key antioxidants located in skin cells. Thedamage appears to be most severe at the surface layers of skin, anddiminishes as one probes into deeper dermal and epidermal layers. Ozone,which is generated by a number of natural sources such as lightning, isalso generated by various industrial sources, such as the burning offossil fuels, and in particular, the emission from automobiles, whichare a leading cause of urban smog. Ozone is formed when reactive oxygenradicals combine with oxygen gas to form a molecule that contains threemoles of oxygen as can be seen in the empirical equation:O₂+O→O₃

In particular, it is now generally recognized that ozone will diminishthe amounts of vitamins C and E in the upper layers of the stratumcorneum as well as oxidize key lipids in the bi-layer of the stratumcorneum. In addition, ozone has been implicated in protein and nucleicacid damage as well. Thiele, J J. et al., “In-Vivo Exposure to OzoneDepletes Vitamins C and E and Induces Lipid Peroxidation in EpidermalLayers of Murine Skin” Free Rad. Biol. Med. 23, 385-391 (1997). VitaminsC and E are key natural antioxidants that offer important defensemechanisms against the ravages of ozone to the deeper layers of theskin. The lipid bi-layer is the most important physical barrier betweenthe interior of the human body and external elements. Deterioration ofthe lipid bi-layer increases trans-epidermal water loss and leads todrying and cracking of the skin. Methods to measure the effects of ozonestress on human skin and human skin-mimics are disclosed in Cotovio, J.et al., “Generation of oxidative stress in human cutaneous modelsfollowing in-vitro ozone exposure,” 15, 357-362 (2001) and Weber, S U.et al., “High-Performance Liquid Chromatography Analysis ofOzone-Induced Depletion of Hydrophilic and Lipophilic Antioxidants inMurine Skin,” Method Enzy., 319, 536-546 (2000). In addition, melanin isa key photo-protective pigment located in the skin and hair that has notpreviously been shown to be a target for ozone degradation. Other keycutaneous lipids that ozone can attack include cholesterol, cholesterolesters, free fatty acids and ceramides that make up the lipid bilayersof the skin.

Damage to nucleic acids can lead to cellular mutations and apoptosis ofimportant skin cells. Such skin cells include, but are not limited tofibroblasts, keratinocytes, dermal papilla, melanocytes, macrophages,corneocytes, Langerhan cells, neutrophils, adipocytes, sebocytes, andnerve cells which reside at the surface of the skin. Likewise, ozone candeteriorate proteins and sugars that comprise the extracellular matrixand natural moisturizers in the skin.

The use of cosmetic products to protect the human body, and inparticular the skin, from the damaging effects of ozone is known. Forexample, Japanese patent JP60215609, published October 1985, disclosesthe use of melanoidins to protect the skin against ozone. Europeanpatent EP1108419, published June 2000, discloses the use of combinationsof hesperetin and curcumin derivatives in topical applications toprotect the skin. International Patent Application WO0059462, publishedOctober 2000, discloses the use of combinations of oxidoreductases andproteinase inhibitors to protect the skin against the damage caused byincreased ozone concentrations in the atmosphere. Likewise,International Patent Application WO0202075, published January 2002,discloses the use of creatine and creatine derivatives as a prophylaxisfor the symptoms of ozone induced skin lesions and inflammatory ordegenerative skin conditions.

In a similar fashion to human skin cells, yeast respond to the presenceof ozone. High concentration of ozone is typically lethal to yeast.However, it has been suggested that lower concentrations of ozone maynot only be nonlethal, but may also influence the yeast to increaseproduction of certain proteins, including glyceraldehyde-3-phosphatedehydrogenase (GAPDH). GAPDH is a key “housekeeper” enzyme that isresponsible for oxidatively converting glyceraldehyde-3-phosphate into1,3-diphosphoglycerate in human skin as part of the glucose cellularenzymatic pathways. It is known that the enzymatic activity of GAPDH isaffected by oxidative stress and ultraviolet light. Hinze, H et. al.,“Effect of ozone on ATP, cytosolic enzymes and permeability ofSaccharomyces cerevisiae,” Arch Microbiol. 147, 105-108 1987.

The use of yeast and derivatives thereof has become quite popular intopical cosmetic and therapeutic applications. For example, active yeastlysates have been sold in the personal care industry for many years.Historically, these products have been marketed and sold as activatorsof tissue oxygen uptake. It has been found that stressed yeast lysateswill stimulate growing cells to increase their oxygen consumption.Additionally, it has been discovered that yeast tissue respiratoryfactors could also stimulate collagen production in skin.

For example, U.S. Pat. No. 2,239,345, issued April, 1941, discloses amethod for improving the uptake of oxygen in living yeast cells byapplication of components derived from yeast. U.S. Pat. No. 5,057,320,issued October, 1991, discloses yeast compositions containing picolinicacid to increase oxygen uptake in living mammalian skin cells.Additionally, U.S. Pat. No. 5,514,591, issued May, 1996, disclosesimproved methods to measure the ability of yeast extracts to stimulateoxygen uptake in human skin cells. Despite previous attempts to increaseoxygen uptake in human skin cells, there is no solution that directlyaddresses the need of ozone protection for the skin.

Therefore, what is needed in the art is a product that provides ozoneprotection to skin cells and skin cell components which include, but arenot limited to nucleic acids, the extracellular matrix proteins, vitaminreservoirs, and the like.

It has been surprisingly found that Saccharomyces cerevisiae, morecommonly known as Baker's Yeast, respond well to growth stresses, suchas heat shock, ozone, peroxides and ultraviolet light. Surprisingly, thestress provides enhanced production of stress response agents, orprotective cell components in the yeast. These stress response agentshave therapeutic effects on human skin cells.

SUMMARY OF THE INVENTION

One aspect of the invention relates to an ozone-stressed yeast lysateproduced by a method including the steps of: exposing growing yeast toan ozone concentration sufficient to produce ozone-stressed yeast;lysing the ozone-stressed yeast to produce an ozone-stressed yeastlysate comprising water-soluble and water-insoluble components; andseparating the water-soluble components from the water-insolublecomponents to produce an ozone-stressed yeast lysate comprising thewater-soluble components.

Another aspect of the invention relates to a personal care compositionincluding: an ozone-stressed yeast lysate and a preservative, whereinthe preservative is selected from the group consisting of alcohol,glycol, parabens, hydantoins, quaternary nitrogen-containing compounds,isothiazolinones, aldehyde-releasing agents, halogenated compounds, andcombinations thereof.

A further aspect of the invention relates to a composition for topicaltreatment of skin, including the ozone-stressed yeast lysate describedabove and a cosmetically acceptable vehicle for application to the skin.

Yet another aspect of the present invention relates to a method forpreparing a personal care composition including an ozone-stressed yeastlysate effective in reducing or minimizing ozone-induced skindegradation when applied to skin cells. The method includes the stepsof: growing yeast in a fermentation broth; exposing the yeast to ozoneby aerating the yeast for a time period of between about five minutesand about seventy-two hours with an aeration gas having an ozoneconcentration of from about 0.0001 millimole (mM) to about 1.0 millimole(mM) based on the total volume of the fermentation broth to produceozone-stressed yeast; lysing the ozone-stressed yeast to produce anozone-stressed yeast lysate; and incorporating the ozone-stressed yeastlysate into a personal care composition.

BRIEF DESCRIPTION OF THE FIGURES

The patent or application file contains at least one drawing executed incolor. Copies of this patent or patent application publication withcolor drawing(s) will be provided by the Office upon request and paymentof the necessary fee.

FIG. 1 is a color photograph of the results from ozone exposure towater, non-ozone-stressed yeast lysate and ozone treated yeast lysateusing an ozone reactive dye as an indicator of ozone degradation.

DETAILED DESCRIPTION OF THE INVENTION

The ozone-stressed yeast lysate of the present invention is obtainedthrough standard fermentation processes known to those skilled in theart. As defined for the purposes of this invention, a yeast lysate is acomposition derived from yeast grown on a nutritional growth media thatis subsequently killed in such as way as to afford a product thatincludes cellular yeast components including, but not limited to, thenutrient broth, cellular protein material, cellular nuclear material,cellular cytoplasmic material, cellular protoplasmic material and/orcell wall components. Typically, the yeast lysate is essentiallywater-soluble. For purposes of this disclosure, water-soluble means 0.1gram of yeast components that are dissolved in 1 gram of water. Asdefined for the purposes of this invention, an ozone-stressed yeast is ayeast that has undergone exposure to ozone, otherwise referred to as“ozone treatment”. An ozone-stressed yeast lysate is a lysate of theozone-stressed yeast. As used herein, the term “yeast” is meant toencompass a single yeast cell, multiple yeast cells, and/or a culture ofyeast cells.

The yeast of the present invention can be of various genus known tothose skilled in the art including, but not limited to: Arthroascus,Aureobasidium, Botryoascus, Brettanomyces, Candida, Citeromyces,Clavispora, Cryptococcus, Debaryomyces, Dekkera, Filobasidium,Guilliermondella, Hansenula, Haneseniaspora, Hormoascus, Klockera,Kluyveromyces, Leucosporidium, Lipomyces, Malassezia, Metschnikowia,Nadsonia, Nematospora, Oosporidium, Pachysolen, Pachytichospora,Penicillium, Pichia, Prototheca, Rhodosporidium, Rhodotorula,Saccharomyces, Saccharomycodes, Saccharomycopsis, Schizosaccharomyce,Schwanniomyces, Sporobolomyces, Sporopachydermia, Tremella,Trichosporan, Trigonopsis, Torulaspora, Torulopsis, Williopsis,Yarrowia, Zygosaccharomyces. Preferably, the yeast is from the genusSaccharomyces. Typically the yeast is Saccharomyces cerevisiae, alsoknown as Baker's yeast.

The yeast is grown on growth media which has peptone and other commongrowth media ingredients. An example of preferred growth media called“yeast fermentation media,” can be found in the “Handbook ofMicrobiological Media,” published by CRC Press.

Methods for growing yeast are known to those skilled in the art.Generally speaking, the yeast can be grown simply in an open-airfermentation vessel, or by using a sealed biological fermentor,available from New Brunswick Scientific, Edison, N.J.

Commercially available ozone generators used for the ozone treatment ofthe yeast can be found at, for example, Erwin Sander ElektroapparatebauGmbH, Uetze-Eltze, Germany. Preferably, the ozonizer Model IV fromSander is used. In most circumstances, an ozone detector is used inaddition to the ozone generator. Suitable ozone detectors are availablefrom Dasibi, Glandale, Calif.

To produce the ozone-stressed yeast of the present invention, the yeastis grown in an environment that contains an effective amount of ozone.Saccharomyces cerevisiae is grown with aeration at 30° Celsius. Aneffective amount of ozone is an amount that is sufficient to cause ayeast response, yet is sub-lethal. By sub-lethal it is meant that atleast 1% of the yeast survive after being exposed to ozone. Therefore,the amount of ozone applied to yeast should allow at least 1% tosurvive. However, the amount of ozone applied to the yeast may allow atleast 10% of the yeast to survive the treatment. In another embodiment,the amount of ozone applied to the yeast should allow at least 50% ofthe yeast to survive the treatment. In a further embodiment, the amountof ozone applied to the yeast should allow at least 80% of the yeast tosurvive the treatment.

The ozone may be introduced to the yeast in any method effective toexpose the yeast to the ozone. For example, the ozone may be introducedto the yeast through an aeration gas which includes the ozone and eitherair or oxygen. The aeration gas is usually at a temperature betweenabout 15° Celsius and about 90° Celsius.

The yeast are exposed to a concentration of ozone for a time periodsufficient to obtain a maximum amount of yeast that have producedcellular components effective against degradation of skin cellcomponents. The yeast may be exposed to the ozone for several minutes toseveral days depending on yeast type, ozone concentration, aerationrates, temperature, and like. Typically the yeast is exposed to an ozoneconcentration between about 0.0001 millimole (mM) to about 1.0 mM for aperiod of 5 minutes to 72 hours. In another example, the yeast isexposed to an ozone concentration between about 0.01 mM and about 0.8 mMfor a period of about 10 minutes to about 60 minutes. In anotherexample, the yeast is exposed to a concentration of ozone between about0.1 mM and about 0.5 mM for a period of from about 15 minutes to about30 minutes.

Illustratively, when the yeast is exposed to ozone for a lengthierperiod of time it is suitable that the yeast is exposed to a lowerconcentration of ozone. Alternatively, when the yeast is exposed toozone for a shorter period of time it is suitable that the yeast isexposed to a higher concentration of ozone. Without wanting to be boundby any theory, it is suggested that the ozone-stressed yeast respond tothe presence of ozone by generating protective agents that counteractthe detrimental effects of ozone.

The ozone-stressed yeast is then lysed to obtain ozone-stressed yeastlysate. The yeast can be lysed by a variety of methods known to oneskilled in the art, including but not limited to, enzymes, high-speedagitation, changes in growth media, autolysis or changes in pH. Theozone-stressed yeast lysate typically contains water-soluble andwater-insoluble components. The water-insoluble components may beseparated from the water-soluble components.

The ozone-stressed yeast lysate may be filtered and purified to removecellular bodies, odor and other undesirable materials. Theozone-stressed yeast lysate is tested to determine whether it issuitable for cosmetic use. Preferably two-dimensional polyacrylamide gelelectrophoresis is performed, and the proteins present in theozone-stressed yeast lysate are quantified.

Without wanting to be bound by any theory, it is suggested that theozone-stressed yeast responds to the presence of the ozone by generatingprotective agents or cellular components, which are capable ofcounteracting the detrimental effects of ozone. It is possible todetermine which proteins are produced by the ozone-stressed yeast byrunning a yeast gene microarray to determine which genes in the yeastare up-regulated or down-regulated as a result of the ozone treatment.The use of yeast gene microarrays allows comparison of changes thatoccur in yeast when different stresses, such as hydrogen peroxide, UVand ozone, are placed on the yeast. Gene microarrays are useful indemonstrating the differences these stresses can have on the proteinsexpressed by stimulating the growing yeast. Saccharomyces cerevesiaegene microarray chips are available from MWG Biotech (High Point, N.C.).

The ozone-stressed yeast lysates may be further purified by any numberof means known to those skilled in the art including, but not limitedto, chromatography, steam distillation, solvent extraction,centrifugation, decantation, filtration, or carbon treatment. Thelysates of the present invention may be further concentrated by anymeans known to those skilled in the art including, but not limited to,evaporation, spray-drying, lyophylization, steam distillation or belt ordrum drying.

The ozone-stressed yeast lysates may be used in personal carecompositions. Such personal care compositions may provide skin cellswith protection from ozone pollution or skin cell component degradationassociated with exposure to ozone. Specifically, the addition ofozone-stressed yeast lysates may control the breakdown of vitamins C andE, DNA, RNA and bilayer lipids, which occurs in skin cells exposed toozone. The personal care composition of the present invention maycontain an effective amount of ozone-stressed yeast lysate and at leastone preservative selected from the group consisting of alcohols,glycols, parabens, quaternary nitrogen-containing compounds,isothiazolinones, aldehyde-releasing agents, antioxidants andhalogenated compounds. Illustrative alcohols include phenoxyethanol,isopropyl alcohol, and benzyl alcohol; illustrative glycols includepropylene, butylene, and pentylene glycol; illustrative parabens (alsoknown as parahydroxybenzoic acids) include methyl, propyl andbutyl-parabens; illustrative quaternary nitrogen-containing compoundsinclude, benzalkonium chloride, and Quaternium 15; illustrativeisothiazolinones include methylisothiazolinone andmethylchloroisothiazolinone; illustrative aldehyde-releasing agentsinclude DMDM hydantoin, imidazolidinyl urea and diazolidinyl urea;illustrative antioxidants include butylated hydroxytoluen andtocopherol, and illustrative halogenated compounds include triclosan,and chlorohexidine digluconate. Examples of preservatives useful for thepurposes of the present invention can be found, for example, inSteinberg, D. “Frequency of Use of Preservatives 2001” Cosmet. Toilet.117, 41-44, (2002) and, “Preservative Encyclopedia” Cosmet. Toilet. 117,80-96 (2002).

An effective amount of ozone-stressed yeast lysate is an amount ofozone-stressed yeast lysate that provides skin cells with adequateprotection from exposure to ozone. Adequate protection may be providedby utilizing a concentration of ozone-stressed yeast lysate in apersonal care composition that is sufficient to impart efficacy againstozone damage to at least a portion of the skin cells that are exposed toozone present in the environment. The effective amount of theozone-stressed yeast lysate is provided by incorporating theozone-stressed yeast lysate into a personal care composition.

Preferably the amount of ozone-stressed yeast lysate is present in apersonal care composition between 0.001% and 100% based on the weight ofthe personal care product. More preferably the ozone-stressed yeastlysate is present in the personal care composition in an amount betweenabout 0.01% and about 50% based on the total weight of the personal carecomposition. Alternatively the ozone-stressed yeast lysate can bepresent in the personal care composition between about 1% and about 10%based on the total weight of the personal care composition.

Additionally, the personal care composition can optionally contain otherfunctional ingredients such as, water, surfactants, emulsifiers,conditioners, emollients, waxes, oils, polymers, thickeners, fixatives,colorants, humectants, moisturizers, stabilizers, diluents, solvents,fragrances and the like, as well as active ingredients such as, forexample, botanicals, neutraceuticals, cosmeceuticals, therapeutics,pharmaceutics, antifungals, antimicrobials, steroidal hormones,antidandruff agents, anti-acne components, sunscreens, preservatives andthe like.

The ozone-stressed yeast lysate can be used in various types of cosmeticformulations including, but not limited to, lotions, ointments, creams,sprays, spritzes, aqueous or aqueous alcoholic mixtures, gels, mousses,patches, pads, masks, moistened cloths and wipes, solid sticks, clearsticks, lipsticks, aerosol creams, anhydrous powders, talcs, tonics,oils, emulsions, and bath salts. Such cosmetic formulations may be usedas topical treatments for skin.

The ozone-stressed yeast lysates of the present invention may includethe lysates alone or they may include the yeast lysates encapsulated invarious chemical delivery vehicles known to those skilled in the art.Such cosmetically acceptable delivery vehicles include, but are notlimited to, liposomes, niosomes, sub-micron emulsions, polymericencapsulants, gels, creams, lotions, and combinations thereof.

The following Examples are intended to illustrate the art of the presentinvention and are not intended to limit the scope of the claims below.

EXAMPLES Example 1 Example of Yeast Lysate from Grown Saccharomyces

Organism and Media

The organism used in this study was S. cerevisiae (Red Star baker'syeast). Stock culture was maintained on a yeast peptide dextrose (YPD)agar slant (Difco). The working culture was maintained in YPD broth at4° C. The fermentation was carried out with the medium containing 10 g/Lyeast extract, 8 g/L NH₄SO₄, 3 g/L KH₂PO₄, 2 g/L MgSO₄, and 0.5 mL/LAntifoam A. Unless otherwise stated, the working volume for fermentationwas 2 liters (L).

Bioreactor

A New Brunswick Bioflo 110 benchtop bioreactor (Edison, N.J.) equippedwith automatic pH, temperature, agitation, dissolved oxygen (DO) andantifoam controls was used. The 2-L vessel was equipped with air in- andout-ports, alkali and medium addition ports, and effluent side ports.Medium pH was maintained at 5.5 by adding 4 M NaOH and/or 4 M H2SO4.Aeration was maintained at 1 vvm (volume of air/working volume offermentor/min) and DO level was kept at 60% by cascading to theagitation. The fermentor was fed with 250 g/L of glucose solution at therate of 1.2 mL/h.

Ozone

Ozone gas was produced from purified extra dry air by an ozone generator(Model Lab2B Ozonia, Elmwood Pk, N.J.). The inlet airflow rate wasmaintained at 0.5 L/min. The ozone generator was set to produce 0.5 g/hof ozone. The ozone-air stream from the ozone generator was mixed with1.5 L/min of air. The mixture of ozone and air (0.5 part/1.5 part) waspurged in to the fermentation medium. Ozone concentration was measuredusing indigo dye (see FIG. 1) and/or a UV spectroscopic method thatindicates ozone at a frequency of 258 nm. All experimental work withozone was done under a chemical hood. An activated carbon columnabsorbed excess ozone.

Stress Conditions

Cells of S. cerevisiae after 48 hours of fermentation (1.0×10⁹ cells/mL)were treated by ozone. The mixture of air and ozone (1.5 part/0.5 part)was purged through the fermentation broth for 15 minutes and 45 minutes(min). The cells were harvested before and after the treatment. Theozone concentration was kept around 0.01 mg/L (0.002 mM). The followingsamples of yeast lysate were: non-treated (A), 15 min (B), and 45 min(C).

Preparation of Yeast Lysate

Samples of S. cerevisiae for analytical tests were taken fromfermentation broth after 48 hours at 1.0×10⁹ cells/mL. Forty-fivemilliliters (mL) of culture sample were centrifuged (15000 rpm for 10min) and washed with distilled water. The precipitate was resuspended in45 mL of 10 mM phosphate buffer of pH 7, supplemented withphenylmethylsulphonyl fluoride (Sigma Chemical Co., St. Louis, Mo.) to 1mM and pepstatin A (Sigma) to a concentration of 10 μM. Forty five mLglass beads (0.5 mm diameter; Biospec Products, USA) were added to thecell suspension. The suspension, in 90 mL container, was inserted into aBeadbeater (Biospec Products) and shaken at homogenization speed for 3min. The sample chamber was cooled during the homogenization step by anice bath. The protein concentration of samples was determined by BCAprotein assay (Sigma). Samples of each lysate were analyzed as describedbelow.

Effect of Ozone Stress on Yeast Protein Expression

Two Dimensional Polyacrylamide Gel Electrophoresis

Two-dimensional electrophoresis was performed according to the method ofO'Farrell (J. Biol. Chem. 250: 4007-4021, 1975) by Kendrick Labs, Inc.(Madison, Wis.) as follows: Isoelectric focusing was carried out inglass tubes of inner diameter 2.0 mm using pH 4-8 2.0% ampholines(Gallard Schlesinger Industries, Inc. Garden City, N.Y.) for 9600volt-hrs. Fifty nanograms of an IEF internal standard, tropomycin, wasadded to each sample. Tropomycin shows two polypeptide spots of similarpI (ionic charge); the lower spot of MW 33,000 and pI 5.2 was markedwith an arrow on the stained gels. The tube gel pH gradient plot forthis set of ampholine was determined with a surface pH electrode.

After equilibration for 10 min in buffer “0” (10% glycerol, 50 mmdithiothreitol, 2.3% SDS and 0.062 M tris, pH 6.8), each tube gel wassealed to the top of a stacking gel that was on top of a 12% acrylamideslab gel (0.75 mm thick). SDS slab gel electrophoresis was carried outfor 4 hours at 12.5 mA/gel. The following proteins from Sigma were addedas molecular weight standards to the agarose that sealed the tube gel tothe slab gel: myosin (220,000), phosphorylase A (94,000), catalase(60,000), actin (43,000), carbonic anhydrase (29,000) and lysozyme(14,000). These standards appear along the basic edge of thesilver-stained 12% acrylamide slab gel.

Limited Computerized Comparisons

Duplicate gels were obtained by the 2-D methodology as described above.One gel from each pair was scanned with a laser densitometer (ModelPDSI, Molecular Dynamics Inc, Sunnyvale, Calif.). The scanner waschecked for linearity prior to scanning with a calibrated NeutralDensity Filter Set (Melles Griot, Irvine, Calif.). The images wereanalyzed using Progenesis Discovery software (version 2003.3, NonlinearTechnology) such that all major spots and all changing spots wereoutlined, quantified and matched on all the gels. The general method ofcomputerized analysis for these pairs included automatic spot findingand quantification, automatic background subtraction (Progenesisalgorithm) and automatic spot matching in conjunction with detailedmanual checking of the spot finding and matching functions.

Results from computerized comparison are given in fold increase ordecrease (difference) of the polypeptides for non-treated sample versus15 min ozone-treated and non-treated versus 45 min ozone treated sample.The differences are calculated from spot percentages (individual spotdensity divided by total density of all measured spots). Increased(up-regulated) and decreased (down-regulated) polypeptide spots with afold difference of ≧3 were taken into consideration.

For purposes of a two-dimensional gel electrophoresis, the term“up-regulated” implies that a protein has been over-expressed, while theterm “down-regulated” implies that the protein has been under-expressed.

Summary of Tables

Table 1. Summary of proteins only present in non-treated yeast lysateand not present in yeast lysate treated for 15 minutes with ozone.

Table 2. Summary of proteins only present in 15 minute ozone treatedyeast lysate and not present in non-treated yeast lysate.

Table 3. Summary of proteins up-regulated (i.e., present but increased)in 15 minute ozone-stressed yeast lysate but not increased innon-treated yeast lysate.

Table 4. Summary of proteins down-regulated (i.e., present butdiminished) in 15 minute ozone-stressed yeast lysate but not diminishedin non-treated yeast lysate.

Table 5. Summary of proteins only present in non-treated yeast lysatebut not present in yeast lysate treated for 45 minutes with ozone.

Table 6. Summary of proteins only present in 45 minute ozone treatedyeast lysate but not present in non-treated yeast lysate.

Table 7. Summary of proteins up-regulated (i.e., present but increased)in 45 minute ozone-stressed yeast lysate but not increased innon-treated yeast lysate.

Table 8. Summary of proteins down-regulated (i.e., present butdiminished) in 45 minute ozone-stressed yeast lysate but not diminishedin non-treated yeast lysate. TABLE 1 The table below indicates molecularweight (MW), pI (ionic charge) and spot number of proteins that werepresent only in non-treated samples. These proteins were not present insamples treated with 15 minutes of ozone. Therefore, four proteins, asshown in the table below, were eliminated due to 15 min of ozonetreatment. (nd = not determined). Spot # pI MW 574 nd nd 575 5.41 21,245576 nd nd 577 nd nd

TABLE 2 The table below indicates molecular weight, pI and spot numberof proteins that were present only in samples exposed to 15 min of ozonetreatment. These proteins were not present in non-treated samples.Therefore, the nine proteins as shown in the table below, were induceddue to 15 min of ozone treatment. (nd = not determined) Spot # pI MW  275.18 85,545 482 6.47 24,435 569 nd nd 472 5.37 26,010 497 5.29 22,733498 5.40 22,846 503 5.24 22,373 505 5.39 22,118 508 5.18 21,034

TABLE 3 The table below indicates molecular weight, pI and spot numberof proteins that were increased in 15 min ozone treated samples. Theseproteins were not increased in non-treated samples. Therefore, sixproteins, as shown in the table, were increased or up-regulated due to15 min of ozone treatment. Spot # pI MW 91 8.33 71,997 473 6.28 25,59520 5.27 89,519 132 5.66 61,063 424 6.38 30,699 507 5.55 21,755

TABLE 4 The table below indicates molecular weight, pI and spot numberof proteins that decreased in 15 min ozone treated samples. Theseproteins did not decrease in non-treated samples. Therefore, twoproteins, as shown in the table, were decreased or down-regulated due to15 min of ozone treatment. Spot # pI MW 535 6.71 18,224 562 nd nd

TABLE 5 The table below indicates molecular weight, pI and spot numberof proteins present only in non-treated samples versus 45 min ozonetreated samples. Thirteen proteins had disappeared due to 45 min ofozone treatment. (nd = not determined). Spot # pI MW 574 nd nd 575 5.4121,245 576 nd nd 577 nd nd 91 8.33 71,997 151 8.00 63,041 206 5.2951,222 320 7.70 37,894 354 7.59 34,851 423 4.88 30,245 461 5.01 25,963521 6.46 20,203 547 5.50 15,498

TABLE 6 The table below indicates molecular weight, pI and spot numberof proteins that were present only in 45 min ozone treated samples. Theproteins were not present in non-treated samples. Therefore, sixproteins, as shown in the table, were induced due to 45 min of ozonetreatment. (nd = not determined) Spot # pI MW 27 5.18 85,545 482 6.4724,435 569 nd nd 580 8.13 50,971 581 7.71 36,880 582 6.89 33,351

TABLE 7 The table below indicates molecular weight, pI and spot numberof proteins that increased in 45 min ozone treated samples. Theseproteins did not increase in non-treated samples. Therefore, sevenproteins, as shown in the table, increased or were up-regulated due to45 min of ozone treatment. Spot # pI MW 424 6.38 30,699 507 5.55 21,755384 7.34 32,405 387 4.77 32,635 451 7.77 26,152 458 7.67 26,019 481 7.0424,181

TABLE 8 The table below indicates molecular weight, pI and spot numberof proteins that decreased in 45 min ozone-treated samples. Theseproteins did not decrease in non-treated samples. Therefore, eightproteins, as shown in the table, decreased, or were down-regulated dueto 45 min of ozone treatment. Spot # pI MW 535 6.71 18,224 2 6.68183,807 4 6.78 167,243 61 4.97 73,486 225 6.03 49,737 316 6.27 39,083533 6.29 18,395 545 9.18 15,513

Example 2 Yeast Gene Microarray Analysis: Comparing Effects of OzoneVerses Hydrogen Peroxide on Gene Expression

To determine whether ozone caused yeast to respond differently than itresponds to hydrogen peroxide, yeast was exposed to either ozone orhydrogen peroxide for the same length of time. The yeast was thensubjected to microarray analysis to determine what genes wereup-regulated and which were down-regulated as a result of thetreatments. The following test protocols were employed in this study.

Yeast Cell Culture and Treatment

Cell cultures of S. cerevisiae were grown as described in more detailabove. At the desired time after treatment, a 3-6 ml aliquot of theyeast culture was obtained and the cell density was measuredspectrophotometrically at 600 nm. Culture samples having an OpticalDensity (OD) between 1 and 2 and were diluted with culture media asnecessary to bring them within this range and the final volume of thealiquot was recorded. The aliquot was then centrifuged to pellet theyeast cells. The supernatant was discarded after centrifugation. Thepellet was resuspended in lysis buffer using a ratio of 100 μl lysisbuffer per ml of original culture volume (volume recorded prior tocentrifuging). An additional ˜200 μl of 0.4-0.5 mm glass beads was addedto assist the lysing procedure.

Because yeast cells are difficult to lyse it was necessary to monitorthe process to make sure that the nucleic acids were being released.After briefly mixing the sample, an initial 2 μl aliquot was obtainedand diluted with 1 ml of nuclease free water. This sample was read at260 nm and served as a “baseline” measurement for free nucleic acids.The remaining untested sample was then vigorously vortexed at 1-minuteintervals. After each interval, a 2 μl aliquot was prepared and read asdescribed above. As the yeast cells were lysed, the absorbance of thealiquot at 260 nm increased and then leveled off as the lysis processwas completed. Total lysing normally occurs within 2-5 rounds ofvortexing. After completing the lysis process for each sample, thesamples stored on dry ice (approximately −75° C.) until analysis waspossible.

RNA Isolation (Ambion RNAqueous Kit)

An equal volume of 64% ethanol was added to a sample of the yeast celllysates prepared as described above, and the tubes were vortexed. Aftercombining all tubes into one container, up to 700 μl of the mixture wastransferred to a glass fiber filter cartridge. The cartridge was loadedinto a 1.5 ml collection tube and was centrifuged for 1 minute at 14,000RPM. The flow-through was discarded and the remaining mixture was loadedinto the filter cartridge and the centrifugation process was repeateduntil all of the mixture had been processed. The filter was then washedto remove any residual cellular debris from the RNA bound to the glassfibers applying 700 μl of wash solution 1 (1 time) and 500 μl of washsolution 2 (2 times) to the filter cartridge and centrifuging at 14,000RPM for 1 minute to pass each wash through the cartridge. After eachwash the flow through was discarded. After the final wash one final spinwas performed without wash solution to remove any residual wash solutionin the filter cartridge. The RNA bound to the glass fibers within thecartridge was then eluted by applying 30 μl of Tris-EDTA buffer (10 mMTris-HCl, 1 mM EDTA, preheated to 70-80° C.) to the cartridge andcentrifuging the cartridge in a new collection tube at 14,000 RPM forone minute. For samples prepared from cell lysates and small tissues theelution process was repeated with an additional 30 μl of preheated TEbuffer. For samples prepared from larger tissues (i.e. full thicknesstissues) the elution process was repeated two additional times. Afterthe RNA was eluted its concentration was quantified using a Ribogreenassay and its quality was assessed via gel electrophoresis.

RNA Concentration Assay (Molecular Probes Ribogreen Assay, Eugene,Oreg.)

The Ribogreen reagent was provided as a stock solution in DMSO. Prior touse the reagent was diluted 2000 fold in TE buffer. The RNA assayrequires 200 μl of diluted Ribogreen reagent per sample to be tested and1 ml of the reagent for the standards. Once prepared the diluted reagentwas stored protected from light. A series of RNA standards were preparedby diluting purified ribosomal RNA derived from E. coli to the followingconcentrations: 2 μg/ml, 1 μg/ml, 200 ng/ml, 40 ng/ml and 0 ng/ml(blank). Prior to assaying, the RNA samples prepared above were diluted1000 fold in TE buffer. For the RNA assay, 100 μl of the diluted samplesor standards were transferred to the wells of a black 96-well plate. Thesamples and standards were assayed in duplicate. After thesamples/standards were added to the plate 100 μl of the dilutedRibogreen assay reagent was added to the wells and the plate was gentlymixed and allowed to incubate for 5-10 minutes protected from the light.After this incubation the plate was read with a fluorometer using anexcitation wavelength of 500 nm and an emission wavelength of 525 nm.

RNA Gel Electrophoresis

A 1% RNA gel was prepared by adding 0.3 g agarose to 21.6 mldiethylpyrocarbonate (DEPC) treated water. The agarose was dissolved byboiling the water in a microwave oven. After the solution was cooled toapproximately 55° C. 5.4 ml of formaldehyde and 3.0 ml 10×MOPS (0.2 MMOPS [pH 7.0], 20 mM sodium acetate, 10 mM EDTA, made in DEPC H₂O andfilter sterilized) was added. After mixing, the agarose gel was cast inthe horizontal gel apparatus with the loading slots placed on the sideof the gel closest to the negative terminal. The gel was allowed to setfor at least 1 hour at room temperature. While the gel set, 175 ml of1×MOPS was prepared by diluting the 10× stock. After the gel was set thecomb was removed and the buffer chamber of the gel apparatus was filledwith 150-175 ml 1×MOPS (enough buffer was added to cover the gel withapproximately 3 mm of buffer). The cover was placed on the apparatus,the electrical leads were attached to the power source, and the emptygel was run at 40 V (4 V/cm) for 5-10 minutes. While the gel was runningthe RNA samples were prepared by transferring ˜1 μg of each sample RNAto a 600 μl PCR tube. DEPC H₂O was used to bring the total volume of allthe samples to a common level and then 1-3 volumes of a gel-loadingbuffer (i.e. 5% glycerol, 1 mM EDTA, 0.025% bromophenol blue, 0.025%xylene cyanol FF, 20% formaldehyde, 50% formamide, 10 μg/ml ethidiumbromide) was added. The samples were denatured by placing them at 65-70°C. for 5-15 minutes and then placing them on ice to cool. The sampleswere carefully loaded into the lanes (each loading slot can hold 10-15μl of sample, depending upon the thickness of the gel) and the gel wasrun at 40 V for 1-3 hours. At the end of the run the RNA was visualizedby placing the gel on a UV transilluminator. An RNA sample was used forsubsequent processing if both the 18 S and 28S ribosomal bands wereclearly visible and there was little or no staining below the 18 S band.

mRNA Amplification (Ambion MessageAmp aRNA kit)

First Strand cDNA Synthesis: To start the first strand synthesis, 5 μgof total RNA for each sample was added to 600 μl PCR tubes and the totalvolume of liquid in the tube was adjusted to 12 μl with DEPC H₂O. Toeach tube, 1 μl of T7 Oligo(dT) primer was added and the tube wasincubated at 70±2° C. for 10 minutes to denature the RNA and then placedon ice to allow the primer to anneal to the poly A ends of the mRNA.After cooling 2 μl of 10×first strand buffer, 1 μl of RNAse inhibitorand 4 μl of dNTP Mix was added to each tube, and the tube was placed at42° C. As soon as the tube was heated, 1 μl of Reverse Transcriptase wasadded and the tubes were returned to 42±2° C. for 2 hours. At the end ofthe two hours the tubes were briefly centrifuged to collect all of thefluid at the bottom of the tube and then placed on ice.

Second Strand Synthesis and cDNA Purification: For the synthesis of thesecond strand of cDNA the following items was added to the tubes above(in this order): 63 μl DEPC H₂O, 10 μl 10×second strand buffer, 4 μldNTP mix, 2 μl DNA Polymerase and 1 μl of RNAse H. The tube was mixedand then incubated at 16±2° C. for 2 hours. Towards the end of the 2hour incubation a sufficient quantity of DEPC H₂O was warmed to 50±2° C.and a cDNA purification filter cartridge was equilibrated with 50 μl ofcDNA binding buffer (one cartridge per sample) for at least 5 minutes.After the samples were finished incubating 250 μl of cDNA binding bufferwas added to each tube and thoroughly mixed. The contents of the PCRtube was transferred to the cDNA purification filter cartridge. Thecartridge was placed in a collection tube and centrifuged at 10,000 RPMfor 1 minute. The flow-through was discarded and 650 μl of cDNA washsolution was added to the cartridge. The cartridge was centrifuged againand the flow-through was discarded, and then centrifuged one last timeto ensure that the wash buffer was completely emptied from the filter.The cDNA was eluted by applying 10 μl of preheated DEPC H₂O to thefilter and centrifuging the filter in a new collection tube at 10,000RPM for one minute. This elution was performed one additional time togive a total volume of 16-18 μl of cDNA solution.

In Vitro Transcription to Synthesize aRNA and aRNA Purification: The invitro transcription began by adding the following to the cDNA solution:4 μl each of T7 ATP solution, T7 CTP solution, T7 GTP solution, T7 UTPsolution, 4 μl of 10× Reaction buffer, and 4 μl of T7 enzyme mix. Thetube was mixed and then incubated at 37±2° C. for 6-14 hours. Towardsthe end of the incubation a sufficient volume of Elution Solution waswarmed to 50-60° C. and an aRNA filter cartridge was equilibrated with100 μl of aRNA binding buffer for at least 5 minutes. At the end of theincubation period, 350 μl of aRNA binding buffer was added to the sampletubes and thoroughly mixed. An additional 250 μl of absolute ethanol wasadded to each tube. The mixture was then transferred to an aRNA filtercartridge; the cartridge was inserted into a collection tube andcentrifuged at 10,000 RPM for 1 minute. The flow-through was discardedand 650 μl of aRNA wash buffer was added to the cartridge followed bycentrifuging at 10,000 RPM for one minute. After discarding the flowthrough the cartridge was spun one final time to remove all traces ofthe wash buffer. The cartridge was transferred to a new collection tubeand 25 μl of prewarmed Elution Solution was added to the cartridge. Thecartridge was incubate for 2 minutes at room temperature and then aRNAwas eluted by centrifuging for 1 minute at 10,000 RPM. This elution wasperformed one additional time to give a total volume of 45-50 μl of aRNAsolution. The final concentration of the aRNA was determined by theRibogreen assay as described above. In addition, the quality of the aRNAwas checked via gel electrophoresis as described above. An aRNA samplewas used for subsequent processing if a broad band of RNA was observed.

Labeling of aRNA with Fluorescent Dyes (PerkinElmer ASAP RNA LabelingKit) and Purification of Labeled aRNA

Labeling: Two tubes were prepared for the labeling process, one for Cy3labeling (green) and one for Cy5 labeling (red). To the Cy3 tube wasadded 2 μg of aRNA prepared from the untreated/control sample (pleasenote, the actual color assignment for each sample is not important,however, for consistency Cy3 is typically used for the untreated sample)and enough DEPC H₂O was added to bring the total volume up to 4 μl. Tothe Cy5 tube was added 2 μg of aRNA prepared from the sample treatedwith the test material and enough DEPC H₂O was added to bring the totalvolume up to 4 μl. To both tubes was added 5 μl of ASAP labeling bufferand 1 μl of the specific dye for the tube (Cy3 or Cy5). The tubes wereincubated for 15 minutes at 85±2° C. At the end of the 15 minutes thetubes were placed on ice to cool and then add 2.5 μl of ASAP stopsolution was added to each tube. The proportions given here were enoughfor analyzing one microarray chip.

Purification: To purify the labeled aRNA, a microcon YM-30 filter columnwas inserted into a collection tube and filled with 400 μl of TE buffer.The Cy3 and Cy5 probes was combined (12.5 μl of each) and then added tothe microcon filter and thoroughly mixed with the TE buffer. The filterwas centrifuged at 12,000 RPM for 8 minutes and the flow through wasdiscarded. The column was washed twice with 400 μl of TE buffer,discarding the flow though each time. After the final wash the filtercolumn was inverted, and placed into a new collection tube andcentrifuged at 12,000 RPM for 2 minutes to collect the probe (the probewas concentrated in a volume of 2-30 μl of residual TE buffer).

Microarray Hybridization and Washing (Yeast Microarray Chips)

For hybridization, 45 μl of 10× control target RNA was mixed with 160 μlof DEPC water and 9 μl of 25× Agilent Fragmentation Buffer. This mixturewas incubated at 60° C. for approximately 30 minutes in a hybridizationoven. At the end of the incubation 225 μl of Agilent HybridizationBuffer was added along with the fluorescent aRNA probes prepared above.The mixture was incubated at 70° C. for 5-10 minutes in a waterbath.During this incubation period, an Agilent SUREHYB hybridization chamberwas prepared by inserting a glass gasket slide into the bottom half ofthe chamber. At the end of the incubation period, the hybridizationmixture (approximately 450 μl) was applied to the glass gasket slide anda Yeast Microarray Chip (High Point, N.C.) was placed face down on topof this gasket such that the hybridization solution was sandwichedbetween the glass gasket slide and the microarray face of the chip. Thetop half of the chamber was then attached and the connecting thumbscrewtightened. After verifying that there was good bubble formation in thechamber, it was placed into the hybridization oven for approximately 17hours (60° C. and rotating at 4 RPM). At the end of the hybridizationperiod the microarray/glass gasket was removed from the SUREHYB chamberand placed in 50 ml of wash solution 1 (room temperature, 6×SSC, 0.005%Triton X-102). After the gasket had fallen away from the microarray, thearray was transferred to 300 ml of fresh wash solution on a magneticstir plate. The array was washed while the solution was mixed at mediumspeed for 10 minutes and then transferred to 300 ml of wash solution 2(0.1×SSX, 0.005% Triton X-102, 4° C.) for 5 minutes. After the finalwash the array was centrifuged at 500 RPM for 5 minutes to dry it.

Microarray Scanning and Analysis

The microarrays were scanned with an Axon GenePix 4100A Scanner with thescanning gains for the scanner were adjusted such that the cy5/cy3 imagecount ratios were between 0.88 and 1.12.

Calculations

RNA Ribogreen Assay

To derive the standard curve for the Ribogreen assay, the relativefluorescent units versus the known RNA concentrations in μg/ml for thestandards were plotted and subjected to regression analysis to establishthe line that best fit these data points. Mean RFU values for the testmaterials and untreated samples was used to estimate the amount of RNApresent in each sample.

Microarray Calculations

The level of gene expression was related to the fluorescence intensityof the probed gene marker on the microarray. Since it is possible tohave differences in labeling efficiency when making the Cy3 and Cy5,probes it is typical to normalize the fluorescence measurements betweenthe two respective dyes before looking at changes in gene expression.Fluorescence intensities for the microarrays were subjected to globalnormalization. The total fluorescent signal for both dyes was normalizedwith a correction factor that would make the ratio of total intensitiesfor both dyes equal to one. After normalizing the fluorescencemeasurements then it was possible to look for changes in geneexpression. Criteria for evaluating changes in gene expression vary fromstudy to study however typically three criteria are required:

-   -   1. The ratio of Cy3/Cy5 (untreated/treated) fluorescence        intensity is greater than 1.5 or less than 0.66. This relates to        a change in gene expression of at least +/−30%    -   2. The fluorescence intensity of the gene marker is greater than        the background intensity.    -   3. The gene feature is clearly marked specifically by the aRNA        probes and is not due to non-specific fluorescence (i.e. SDS        streaks will leave fluorescent trails).        The data in the first two criteria were filtered via computer        analysis of the data. The last criterion requires a visual        inspection of the array spot to confirm.        Results of Microarray Analysis Comparing Ozone Stress to        Hydrogen Peroxide Stress

Using the protocols outlined above, two sets of yeast cells werestressed using either ozone or hydrogen peroxide. One set of yeast cellswas exposed to 0.002 millimole (0.01 mg/L) of ozone for approximatelyone hour, while another set of yeast cells was exposed to 0.002millimole (0.01 mg/L) of hydrogen peroxide for approximately one hour.Analysis of the genes that were subsequently affected by the stress werecompared against untreated controls to determine which genes wereup-regulated and down-regulated using the criteria defined above.

For purposes of gene microarray analysis, the term “up-regulation” or“up-regulated” implies that the gene is over-expressing RNA. The term“down-regulation” or “down-regulated” implies RNA is beingunder-expressed.

Results of Ozone and Hydrogen Peroxide Stressing on Yeast Compared toUntreated Yeast

Yeast that was treated with ozone showed up-regulation of 570 genes anddown-regulation of 342 genes. Yeast that was treated with hydrogenperoxide showed up-regulation of 502 genes and down-regulation of 57genes.

Comparison of Genes Up-Regulated and Down-Regulated in Ozone VerseHydrogen Peroxide Stressed Yeast

Of the entire yeast genome present on the microarray, 570 genes wereup-regulated in ozone-stressed yeast with 148 (26%) of them beingdifferent than those up-regulated by hydrogen peroxide. Likewise, of the502 genes up-regulated by hydrogen peroxide, 80 (15.0%) were differentthan those up-regulated for ozone stressed yeast.

Of the 342 genes down-regulated by ozone stressing yeast, 321 (93.8%)were not down-regulated by hydrogen peroxide stress. Likewise, of the 57genes down-regulated by hydrogen peroxide stress, 36 (63%) were notdown-regulated by ozone stress.

Of the genes observed in the microarray analysis, it was noted thatGAPDH was up-regulated in the presence of ozone, while it was notaffected by hydrogen peroxide consistent with the earlier publishedscientific studies discussed above.

Example 3 In Vitro Protective Effect of Ozone-Stressed Yeast Lysate onCarmine Dye Oxidation

In-vitro studies were performed by the degradation of potassiumindigotrisulfonic acid upon exposure to ozone (Wentworth Jr. et al.2003). Samples of ozone-stressed (or ozone treated) yeast lysate,non-ozone-stressed treated yeast lysate, and distilled water werecompared. Approximately 36 mL of indigo reagent was mixed with 100 mL ofsample to give an absorbance of 0.5. The final concentrations of yeastlysate samples were around 2%. Samples were then purged with 1.5 L/minof ozone/air stream containing 10 mg/L of ozone for 10 minutes.Absorbance values for samples were measured at 600 nm at different timeintervals. Ozone has the unique ability to cleave the double bond inindigo to give the colorless isatin sulfonic acid compound, see below.

Results from ozone exposure of water, non-ozone-stressed yeast lysateand ozone treated yeast lysate are shown in the photograph in FIG. 1.The ozone-stressed yeast lysate showed increased protection against theoxidizing power of ozone and less degradation to indigo potassium indigotrisulfonate compared to water and nontreated yeast lysate. This studysuggests that ozone-stressed yeast lysate contains protective agents toretard the degradation of indigo dye. FIG. 1 shows the visualdifferences among the four samples. The first jar in the photograph,labeled “control”, contains water and the indigo dye. The control jardoes not contain yeast or yeast lysates and the solution in this jar wasnot subjected to ozone treatment. The second jar, labeled “water”,contains water and the indigo dye. This jar also does not contain yeastor yeast lysate, however the solution in this jar was subjected to anozone treatment to show how the ozone reacts with the indigo dye.

The third jar, labeled “ozone treated yeast”, contains ozone-stressedyeast lysate in addition to water and the indigo dye. The solution inthis jar was subjected to ozone treatment to show how the ozone reactswith the indigo dye in the presence of ozone-stressed yeast lysate.

The fourth jar, labeled “non-treated yeast”, contains non-ozone-stressedyeast lysate in addition to water and the indigo dye. The solution inthis jar was also subjected to ozone treatment to show how the ozonereacts with the indigo dye in the presence of non-ozone-stressed yeastlysate.

This test suggests several things, including: the indigo reagent isreactive to ozone; adding yeast lysate to the water and indigo dyesolution provides some protection to the indigo dye from ozonedegradation; and adding ozone-stressed yeast lysate to the water andindigo dye solution provides additional protection to the indigo dyefrom ozone degradation.

Example 4

Samples of the ozone-stressed yeast lysates were incorporated into aliposome comprising phospholipid and lecithin obtained from soybeans.The lysate was slurried together with the phospholipid and lecithincomponents and the mixture was homogenized using a high-pressurehomogenizer obtained from Hydraulic Engineering Corporation (Brea,Calif.). The milky white mixture contained the ozone-stress yeast lysateencapsulated with the liposomal components.

Example 5

Samples of ozone-stressed yeast lysate were encapsulated in amaltodextrin and spray-dried to provide an essentially anhydrous powderof maltodextrin-encapsulated yeast lysate using the methodologiesoutlined in WO 2003/068161.

The following Proposed Examples illustrate skin care compositionsaccording to the present invention that can be prepared using theozone-stressed yeast lysate prepared using the method in Example 1.

Proposed Example

This example illustrates a high internal phase water-in-oil emulsionincorporating the ozone-stressed yeast lysate prepared as disclosed inExample 1. Ingredient wt % 1,3-dimethyl-2-imidazolidinone 0.2polyoxyethylene (2) oleyl ether¹ 5.0 Bentone 38 0.5 MgSO₄.7H₂O 0.3Preservative² 0.01 Ozone-Stressed Yeast Lysate 10.0 Water to 100¹For example, Brij 92 is polyoxyethylene (2) oleyl ether.²Such as an aldehyde-releasing agent, for example DMDM Hydantoin.

Proposed Example

This example illustrates an oil-in-water cream incorporating theozone-stressed yeast lysate prepared as disclosed in Example 1.Ingredient wt % Mineral Oil 4 1,3-dimethyl-2-imidazolidinone 1 cetylalcohol POE (10)¹ 4 cetyl alcohol² 4 Triethanolamine 0.75Butane-1,3-diol 3 Xanthan gum 0.3 Methyl, Propyl and Butyl Paraben 0.01Ozone-Stressed Yeast Lysate 10.0 Water to 100¹For example, Brij 56 is cetyl alcohol POE (10)²For example, Alfol 16RD is cetyl alcohol

Proposed Example

This example illustrates an alcoholic lotion incorporating aozone-stressed yeast lysate prepared as disclosed in Example 1.Ingredient wt % 1,3-dimethyl-2-imidazolidinone 0.3 Ethanol 40Ozone-Stressed Yeast Lysate 10.0 Water to 100

Proposed Example

This example illustrates a sub-micron emulsion concentrate that containsa ozone-stressed yeast lysate prepared as described in Example 3.Ingredient wt % Trimethylolpropane Tricaprylate/Tricaprate 18.0 Glycerin8.0 Cetearyl alcohol 2.0 Ceteareth 20 2.0 Glyceryl stearate 2.0 BHT 0.01Ozone-Stressed Yeast Lysate 10.0 Water to 100

Proposed Example

Ingredient wt % Water 89 Ozone-stressed yeast lysate 10 preservative(i.e. oxyethanol) 1

1. An ozone-stressed yeast lysate produced by a method comprising thesteps of: exposing growing yeast to an ozone concentration sufficient toproduce ozone-stressed yeast; lysing the ozone-stressed yeast to producean ozone-stressed yeast lysate comprising water-soluble andwater-insoluble components; and separating the water-soluble componentsfrom the water-insoluble components to produce an ozone-stressed yeastlysate comprising the water-soluble components.
 2. An ozone-stressedyeast lysate produced by method according to claim 1, wherein the ozoneconcentration is between about 0.0001 millimole (mM) and about 1.0millimole (mM).
 3. An ozone-stressed yeast lysate produced by a methodaccording to claim 1, wherein the yeast is lysed by at least one enzyme,high-speed agitation, autolysis or a change in pH.
 4. A personal carecomposition comprising: an ozone-stressed yeast lysate; and apreservative, wherein the preservative is selected from the groupconsisting of alcohol, glycol, parabens, hydantoins, quaternarynitrogen-containing compounds, isothiazolinones, aldehyde-releasingagents, halogenated compounds, and combinations thereof.
 5. A personalcare composition of claim 4, wherein the ozone-stressed yeast lysate ispresent in a concentration between about 0.0001% and about 100% byweight based on the total weight of the personal care composition.
 6. Apersonal care composition of claim 5, wherein the ozone-stressed yeastlysate is present in a concentration between about 0.01% and about 50%by weight based on the total weight of the personal care composition. 7.A personal care composition of claim 6, wherein the ozone-stressed yeastlysate is present in a concentration between about 1% to about 10% byweight based on the total weight of the personal care composition.
 8. Apersonal care composition of claim 4, wherein the preservative ispresent in a concentration between about 0.01% to about 10% by weightbased on the total weight of the personal care composition.
 9. Apersonal care composition of claim 4, wherein the ozone-stressed yeastlysate is encapsulated with another component to provide a time-releasecharacteristic to the ozone-stressed yeast lysate.
 10. A personal carecomposition of claim 9, wherein the other component is selected from thegroup consisting of lyposomes, niosomes, sub-micron emulsions, polymericencapsulants, gels, creams, lotions, and combinations thereof.
 11. Apersonal care composition according to claim 4, wherein theozone-stressed yeast lysate comprises at least one cellular componentselected from the group consisting of cellular protein material,cellular nuclear material, cellular cytoplasmic material, cellularprotoplasmic material, cell wall components, and combinations thereof.12. A personal care composition according to claim 4, wherein theozone-stressed yeast lysate is essentially water-soluble.
 13. Acomposition for topical treatment of skin, comprising the ozone-stressedyeast lysate of claim 1 and a cosmetically acceptable vehicle forapplication to the skin.
 14. A method for preparing a personal carecomposition comprising an ozone-stressed yeast lysate effective inreducing or minimizing ozone-induced skin degradation when applied toskin cells, the method comprising the steps of: growing yeast in afermentation broth; exposing the yeast to ozone by aerating the yeastfor a time period of between about five minutes and about seventy-twohours with an aeration gas having an ozone concentration of from about0.0001 millimole (mM) to about 1.0 millimole (mM) based on the totalvolume of the fermentation broth to produce ozone-stressed yeast; lysingthe ozone-stressed yeast to produce an ozone-stressed yeast lysate; andincorporating the ozone-stressed yeast lysate into a personal carecomposition.
 15. A method for preparing a personal care compositionaccording to claim 14 wherein the aeration gas has a temperature betweenabout 15° C. and about 90° C.
 16. A method for preparing a personal carecomposition according to claim 14, wherein the yeast is aerated for atime period between about 10 minutes and about 60 minutes with anaeration gas having an ozone concentration of from about 0.01 mM toabout 0.8 mM.
 17. A method for preparing a personal care compositionaccording to claim 16, wherein the yeast is aerated for a time periodbetween about 15 minutes and about 30 minutes with an aeration gashaving an ozone concentration of from about 0.1 mM to about 0.5 mM. 18.A method for preparing a personal care composition according to claim14, wherein the personal care composition further comprises at least oneingredient selected from the group consisting of water, surfactants,emulsifiers, conditioners, emollients, waxes, oils, polymers,thickeners, fixatives, colorants, humectants, moisturizers, stabilizers,diluents, solvents, fragrance, botanicals, neutraceuticals,cosmeceuticals, antifungals, antimicrobials, steroidal hormones,antidandruff agents, anti-acne components, sunscreen, preservatives, andcombinations thereof.